jerriab Jan 9, 2025 4 min read Semaglutide has emerged as a groundbreaking solution for weight management and improved metabolic health
Conclusion Nausea after the first dose of semaglutide is a common, manageable, and usually temporary hurdle on the path to better health
David: Right, and that's not illegal
Once a niche class of diabetes drugs, GLP-1 agonists have become the cornerstone of a global race to conquer obesity, a disease that has more than doubled in prevalence since 1990 and now affects over 42% of U.S
These include a body mass index (BMI) of 35 kg/m or above (or 32.5 kg/m or above for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity, and previous unsuccessful attempts at weight loss through diet and exercise